Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences

Pasithea Therapeutics Corp. (KTTA) — -- Company will hold one-on-one investor meetings at the 12th Annual Cantor Global Healthcare Conference (September 9-11) and will present at the H.C. Wainwright 28th Annual Global Investment Conference (September 14-16) -- MIAMI, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) ("Pasithea" or the "Company"), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic oral MEK inhibitor, for the long-term treatment of chronic diseases inc

Source: GlobeNewswire — read the full announcement there.

See our Pasithea Therapeutics company profile for background, links, and more Pasithea Therapeutics news.